Abstract
In the heart and other tissues, beta-adrenergic desensitization occurs during treatment with catecholamines. In heart failure, a strong sympathetic activation has been observed and is the cause of beta-adrenergic desensitization in this condition. On the receptor level, there is a downregulation of beta 1-adrenergic receptors as well as an uncoupling of beta 2-adrenoceptors. The latter mechanism has been related to an increased activity and gene expression of beta-ARK2 in failing myocardium leading to phosphorylation and uncoupling of receptors. In addition, an increase of inhibitory G-protein alpha-subunits (Gi alpha) has been suggested to be causally linked to adenylyl cyclase desensitization in heart failure. In contrast, the catalytic subunit of adenylyl cyclase, stimulatory G-protein alpha-subunits and beta gamma-subunits have been observed to be unchanged. Recently, evidence has been raised that increases of Gi alpha also depress adenylyl cyclase in compensated cardiac hypertrophy in monogenic and polygenic as well as in secondary hypertension. These increases of Gi alpha can suppress adenylyl cyclase in the absence of beta-adrenergic receptor downregulation. Since cardiac hypertrophy in pressure overload is a strong pred...Continue Reading
References
Oct 1, 1979·Circulation Research·E A WoodcockC I Johnston
Jul 1, 1992·Hypertension·M BöhmE Erdmann
May 1, 1992·British Journal of Pharmacology·L A Brown, S E Harding
Oct 1, 1992·Journal of Hypertension·M BöhmE Erdmann
Sep 1, 1991·Circulation·M R BristowJ Murray
Mar 1, 1991·Circulation Research·M BöhmE Erdmann
Jan 1, 1990·Journal of Molecular and Cellular Cardiology·P SchnabelE Erdmann
Aug 1, 1990·Hypertension·M C MichelP A Insel
Oct 1, 1990·Circulation·M BöhmE Erdmann
Feb 1, 1987·Circulation·M D FeldmanJ P Morgan
Jul 1, 1988·The Journal of Clinical Investigation·A M FeldmanC Van Dop
Oct 22, 1988·Lancet·J NeumannP Kalmar
Feb 1, 1987·Journal of Molecular and Cellular Cardiology·T MurakamiH Yasuda
Oct 19, 1972·The New England Journal of Medicine·W B KannelM Feinleib
Feb 15, 1981·Biochemical Pharmacology·P RobberechtJ Christophe
Feb 1, 1984·Circulation Research·M H Ayobe, R C Tarazi
Sep 27, 1984·The New England Journal of Medicine·J N CohnT Rector
Oct 1, 1984·The American Journal of Cardiology·K SwedbergK Chatterjee
Apr 1, 1982·The American Journal of Cardiology·G S FrancisJ N Cohn
Mar 1, 1995·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·B NürnbergG Schultz
Jan 1, 1995·Journal of the American College of Cardiology·M BöhmE Erdmann
Feb 1, 1995·The American Journal of Medicine·M BöhmE Erdmann
Dec 1, 1994·Hypertension·M BöhmE Erdmann
Feb 1, 1994·Journal of Molecular and Cellular Cardiology·M BöhmM Steinfath
Nov 1, 1993·Hypertension·M BöhmE Erdmann
Citations
Feb 17, 1998·Basic Research in Cardiology·C NakagawaM Nakagawa
Oct 7, 1998·Journal of Applied Physiology·T BinzoniM Ferrari
May 20, 1999·Circulation·V J OwenS E Harding
Nov 14, 2000·Circulation Research·K NagataR M Mortensen
Feb 13, 2001·American Journal of Physiology. Heart and Circulatory Physiology·M JainR M Mortensen
May 14, 2008·Molecular and Cellular Biochemistry·C PottK Brixius
Jun 26, 2009·European Journal of Heart Failure·Kumar PandyaOliver Smithies
Oct 12, 2000·Cellular Signalling·S ChakrabortiG Shaw
Jul 3, 2021·Cells·Mariona Guitart-MampelMaria E Solesio
Oct 26, 2005·International Journal of Cardiology·M Silvina Lo PrestiPatricia A Paglini-Oliva